May 12, 2020 / 12:55 PM / in 3 months

Elliott again pushes Alexion Pharma to explore a sale

May 12 (Reuters) - Activist investor Elliott Management on Tuesday revived its call for a sale of Alexion Pharmaceuticals Inc, months after the company rejected the hedge fund's earlier demand.

Elliott also highlighted Alexion's $1.41 billion deal to buy Portola Pharmaceuticals Inc announced earlier this month, saying it erased about $1.7 billion from the company’s market capitalization in a single day. (Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below